Vascular Biogenics Prices its Initial Public Offering

Reston – November 5, 2014 – Cooley advised the underwriters on Vascular Biogenics Ltd.'s initial public offering. Vascular Biogenics is an Israel-based clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of first-in-class treatments for cancer and immune-inflammatory diseases. The company now trades on The NASDAQ Global Stock Market under the symbol "VBLT."

Deutsche Bank Securities acted as the sole book-running manager for the offering. JMP Securities and Oppenheimer & Co. acted as co-managers for the offering.

The Cooley corporate and securities team advising the underwriters was comprised of partners Brent Siler and Darren DeStefano and associates Hosea Chang and Mark Ballantyne.

Critical support was provided by partner Natasha Leskovsek (health care and life sciences regulatory); partner Bonnie Weiss McLeod and associates Fraser Brown and Sandhya Deo (intellectual property); and partner Susan Philpot (tax).

About Cooley LLP

Cooley's attorneys solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and bet-the-company litigation, often where innovation meets the law.

Cooley has 800 lawyers across 11 offices in the United States and China.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.